Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALL (NCT03249870) | Versailles Hospital | 2017-12-28 |
Track Acute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) automatically
Every clearance here is in the API, with alerts when new ones post.